{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:25:58Z","timestamp":1790875558091,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ophtha.2015.03.010","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T23:01:42Z","timestamp":1429311702000},"page":"1517-1521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Prognosis of Ocular Myasthenia Gravis"],"prefix":"10.1016","volume":"122","author":[{"given":"Lina","family":"Nagia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9128-7064","authenticated-orcid":false,"given":"Joao","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawla","family":"Abusamra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne T.","family":"Cornblath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Eggenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2015.03.010_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2004-829585","article-title":"Pathophysiology of myasthenia gravis","volume":"24","author":"Hughes","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1016\/j.ophtha.2015.03.010_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ana.410140504","article-title":"Prognosis of ocular myasthenia","volume":"14","author":"Bever","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2015.03.010_bib3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/jnnp.52.10.1121","article-title":"The natural course of myasthenia gravis: a long term follow up study","volume":"52","author":"Oosterhuis","year":"1989","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ophtha.2015.03.010_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.1988.tb06970.x","article-title":"Ocular myasthenia: diagnostic and therapeutic problems","volume":"77","author":"Evoli","year":"1988","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ophtha.2015.03.010_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archneur.60.2.243","article-title":"Development of generalized disease at 2 years in patients with ocular myasthenia gravis","volume":"60","author":"Kupersmith","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ophtha.2015.03.010_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jnnp.62.2.156","article-title":"Ocular myasthenia gravis: response to long-term immunosuppressive treatment","volume":"62","author":"Sommer","year":"1997","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ophtha.2015.03.010_bib7","first-page":"497","article-title":"Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients","volume":"38","author":"Osserman","year":"1971","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.ophtha.2015.03.010_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2008.05.023","article-title":"Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients","volume":"273","author":"Hong","year":"2008","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ophtha.2015.03.010_bib9","first-page":"1314","article-title":"Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up","volume":"256","author":"Kupersmith","year":"2009","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ophtha.2015.03.010_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00041327-200312000-00002","article-title":"Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis","volume":"23","author":"Mee","year":"2003","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2015.03.010_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00041327-200312000-00001","article-title":"Does early immunotherapy reduce the conversion of ocular myasthenia gravis to generalized myasthenia gravis?","volume":"23","author":"Kupersmith","year":"2003","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.ophtha.2015.03.010_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01215447","article-title":"Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects","volume":"84","author":"Sommer","year":"1993","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2015.03.010_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1749-6632.1987.tb51317.x","article-title":"The course of myasthenia gravis and therapies affecting outcome","volume":"505","author":"Grob","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ophtha.2015.03.010_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/mus.21555","article-title":"Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis","volume":"41","author":"Allen","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ophtha.2015.03.010_bib15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/ene.12057","article-title":"The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis","volume":"20","author":"Zach","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ophtha.2015.03.010_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2003.08.017","article-title":"The effect of prednisone on the progression from ocular to generalized myasthenia gravis","volume":"217","author":"Monsul","year":"2004","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ophtha.2015.03.010_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0404.1996.tb00517.x","article-title":"Myasthenia gravis in the elderly: a hospital based study","volume":"93","author":"Antonini","year":"1996","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ophtha.2015.03.010_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0008-4182(01)80063-6","article-title":"Myasthenia gravis with ocular involvement in older patients","volume":"36","author":"Weizer","year":"2001","journal-title":"Can J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642015002419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642015002419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T07:56:06Z","timestamp":1537689366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642015002419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0161642015002419"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.010","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosis of Ocular Myasthenia Gravis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}